Case Description
In the IMS Health case, the Court of Justice of the European Union (hereinafter “CJEU”) clarified the ‘exceptional circumstances’ test used to determine whether a refusal to license an intellectual property right (hereinafter “IPR”) constitutes an abuse of a dominant position under Art. 102 of the Treaty on the Functioning of the European Union.
Decision Year
2004
Case Summary
Document
Decision Link
Jurisdiction